Feasibility of a Physical Therapy Intervention on Older Adults With Hyperkyphosis or Forward Head… (NCT04114331) | Clinical Trial Compass
CompletedNot Applicable
Feasibility of a Physical Therapy Intervention on Older Adults With Hyperkyphosis or Forward Head Posture
United States24 participantsStarted 2018-02-26
Plain-language summary
The original intent was to use a manual therapy and therapeutic exercise intervention with older patients with pneumonia post-hospitalization. It was hypothesized that the physical therapy intervention would have a positive impact on posture, physical function, pulmonary function, gait, quality of life, and ultimately readmission. This patient population was found to be not feasible to recruit and the study target population was expanded to include older community dwelling adults with pneumonia, chronic obstructive pulmonary disease (COPD), or hyperkyphosis.
Who can participate
Age range
50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* at least 50 years of age
* hyperkyphosis, forward head posture, pneumonia, or chronic obstructive pulmonary disease (COPD)
* community dwelling
* self report of ability to walk 10 feet or greater with or without an assistive device
* ability to perform informed consent
* ability to transport to research facility
* ability to read and write in English or Spanish
Exclusion Criteria:
* Inability to perform informed consent
* Inability to follow directions
* Inability to perform transfers, sit, and stand independently
* Inability to ambulate 10 feet or more with or without an assistive device
* Inability to perform pulmonary function testing
* Inability to fully participate in testing and measures
* Inability to fully participate in the intervention
* Severe claustrophobia
* Unable to tolerate physical touch
* Morbid obesity (BMI greater than 40)
* History of prior lung disease such as cancer or transplant
* History of comorbidity that would affect lung function such as neuromuscular disease (ALS, MS), collagen disease (SLE), cardiovascular disease (CHF), or musculoskeletal disease with an autoimmune component (Ankylosing Spondylosis, RA).
* A prior discharge within 30 days of hospitalization for pneumonia or COPD
* Discharge against medical advice
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Posture, as measured by change in height
Timeframe: through study completion (4 weeks) and one time follow-up at an average of 6 months
2
Posture, as measured by change in kyphotic index
Timeframe: through study completion (4 weeks) and one time follow-up at an average of 6 months
3
Posture, as measured by change in block test
Timeframe: through study completion (4 weeks) and one time follow-up at an average of 6 months
4
Posture, visual change in digital photos
Timeframe: through study completion (4 weeks) and one time follow-up at an average of 6 months
Trial details
NCT IDNCT04114331
SponsorThe University of Texas Medical Branch, Galveston